Drug intelligence / Profile preview

CartiONE

Development stage: Unknown
Lead developer: Cartilage Repair Systems
Modality: Cell Therapies, Device-based Delivery → Drug Delivery Systems
Administration: Implant, Intraarticular

Overview

CartiONE is a medical technology developed by Cartilage Repair Systems BV for the single-stage repair of symptomatic focal articular-cartilage lesions of the knee. It utilizes autologous articular chondrocytes and bone marrow mononucleated cells, which are isolated and mixed in the operating room, then seeded into a biodegradable, biocompatible, load-bearing copolymer (PolyActive) scaffold for implantation. This approach aims to initiate cartilage repair using the patient's own cells, avoiding cell culturing and a second implantation surgery.

Brand names: CartiONE
Other names: CartiONE Cell-Based Cartilage Repair

Beyond the preview

Go deeper on CartiONE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CartiONE.

Explore the full profile